nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextropropoxyphene—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.0343	0.0437	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.0343	0.0437	CbGbCtD
Dextropropoxyphene—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.0296	0.0377	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.0296	0.0377	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.0288	0.0366	CbGbCtD
Dextropropoxyphene—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.0288	0.0366	CbGbCtD
Dextropropoxyphene—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.026	0.0331	CbGbCtD
Dextropropoxyphene—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.026	0.0331	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.026	0.0331	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.026	0.0331	CbGbCtD
Dextropropoxyphene—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0248	0.0315	CbGbCtD
Dextropropoxyphene—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0248	0.0315	CbGbCtD
Dextropropoxyphene—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0203	0.0259	CbGbCtD
Dextropropoxyphene—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0191	0.0243	CbGbCtD
Dextropropoxyphene—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0191	0.0243	CbGbCtD
Dextropropoxyphene—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.0188	0.0239	CbGbCtD
Dextropropoxyphene—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.0188	0.0239	CbGbCtD
Dextropropoxyphene—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0186	0.0237	CbGbCtD
Dextropropoxyphene—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.018	0.0229	CbGbCtD
Dextropropoxyphene—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0175	0.0222	CbGbCtD
Dextropropoxyphene—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0175	0.0222	CbGbCtD
Dextropropoxyphene—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0173	0.022	CbGbCtD
Dextropropoxyphene—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0173	0.022	CbGbCtD
Dextropropoxyphene—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0158	0.0201	CbGbCtD
Dextropropoxyphene—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0158	0.0201	CbGbCtD
Dextropropoxyphene—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0149	0.019	CbGbCtD
Dextropropoxyphene—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0145	0.0184	CbGbCtD
Dextropropoxyphene—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0136	0.0174	CbGbCtD
Dextropropoxyphene—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0132	0.0169	CbGbCtD
Dextropropoxyphene—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0131	0.0167	CbGbCtD
Dextropropoxyphene—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0131	0.0167	CbGbCtD
Dextropropoxyphene—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0126	0.016	CbGbCtD
Dextropropoxyphene—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.012	0.0152	CbGbCtD
Dextropropoxyphene—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.012	0.0152	CbGbCtD
Dextropropoxyphene—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0118	0.015	CbGbCtD
Dextropropoxyphene—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0111	0.0141	CbGbCtD
Dextropropoxyphene—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0111	0.0141	CbGbCtD
Dextropropoxyphene—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.01	0.0128	CbGbCtD
Dextropropoxyphene—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.01	0.0128	CbGbCtD
Dextropropoxyphene—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00867	0.011	CbGbCtD
Dextropropoxyphene—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00842	0.0107	CbGbCtD
Dextropropoxyphene—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00761	0.00969	CbGbCtD
Dextropropoxyphene—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00761	0.00969	CbGbCtD
Dextropropoxyphene—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0073	0.00929	CbGbCtD
Dextropropoxyphene—OPRM1—nerve—acquired immunodeficiency syndrome	0.00146	0.143	CbGeAlD
Dextropropoxyphene—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000662	0.065	CbGeAlD
Dextropropoxyphene—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000588	0.0577	CbGeAlD
Dextropropoxyphene—OPRD1—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.000584	0.0284	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.000512	0.0249	CbGpPWpGaD
Dextropropoxyphene—OPRD1—nervous system—acquired immunodeficiency syndrome	0.00048	0.0471	CbGeAlD
Dextropropoxyphene—OPRD1—central nervous system—acquired immunodeficiency syndrome	0.000462	0.0453	CbGeAlD
Dextropropoxyphene—OPRK1—nervous system—acquired immunodeficiency syndrome	0.00046	0.0452	CbGeAlD
Dextropropoxyphene—OPRD1—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.000453	0.022	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000448	0.044	CbGeAlD
Dextropropoxyphene—OPRK1—central nervous system—acquired immunodeficiency syndrome	0.000443	0.0435	CbGeAlD
Dextropropoxyphene—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000441	0.0433	CbGeAlD
Dextropropoxyphene—OPRM1—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.000433	0.021	CbGpPWpGaD
Dextropropoxyphene—OPRM1—blood—acquired immunodeficiency syndrome	0.000403	0.0396	CbGeAlD
Dextropropoxyphene—OPRK1—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.000397	0.0193	CbGpPWpGaD
Dextropropoxyphene—OPRM1—spinal cord—acquired immunodeficiency syndrome	0.000389	0.0381	CbGeAlD
Dextropropoxyphene—OPRD1—brain—acquired immunodeficiency syndrome	0.000367	0.036	CbGeAlD
Dextropropoxyphene—OPRK1—brain—acquired immunodeficiency syndrome	0.000352	0.0345	CbGeAlD
Dextropropoxyphene—OPRM1—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.000336	0.0163	CbGpPWpGaD
Dextropropoxyphene—OPRM1—nervous system—acquired immunodeficiency syndrome	0.000327	0.0321	CbGeAlD
Dextropropoxyphene—OPRD1—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.000326	0.0159	CbGpPWpGaD
Dextropropoxyphene—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000322	0.00175	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000321	0.00175	CcSEcCtD
Dextropropoxyphene—Agitation—Efavirenz—acquired immunodeficiency syndrome	0.00032	0.00174	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00032	0.00174	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000319	0.00174	CcSEcCtD
Dextropropoxyphene—Eye disorder—Saquinavir—acquired immunodeficiency syndrome	0.000318	0.00173	CcSEcCtD
Dextropropoxyphene—Constipation—Stavudine—acquired immunodeficiency syndrome	0.000318	0.00173	CcSEcCtD
Dextropropoxyphene—Shock—Zidovudine—acquired immunodeficiency syndrome	0.000318	0.00173	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.000317	0.00173	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.000317	0.00173	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000316	0.00172	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Saquinavir—acquired immunodeficiency syndrome	0.000316	0.00172	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000316	0.00172	CcSEcCtD
Dextropropoxyphene—OPRM1—central nervous system—acquired immunodeficiency syndrome	0.000315	0.0309	CbGeAlD
Dextropropoxyphene—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.000315	0.00172	CcSEcCtD
Dextropropoxyphene—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.000314	0.00171	CcSEcCtD
Dextropropoxyphene—Syncope—Efavirenz—acquired immunodeficiency syndrome	0.000312	0.0017	CcSEcCtD
Dextropropoxyphene—Discomfort—Indinavir—acquired immunodeficiency syndrome	0.00031	0.00169	CcSEcCtD
Dextropropoxyphene—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.000308	0.00168	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000308	0.00167	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.000307	0.00167	CcSEcCtD
Dextropropoxyphene—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000307	0.00167	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000307	0.00167	CcSEcCtD
Dextropropoxyphene—OPRD1—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.000307	0.0149	CbGpPWpGaD
Dextropropoxyphene—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.000306	0.00167	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Efavirenz—acquired immunodeficiency syndrome	0.000306	0.00167	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000305	0.00166	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.000305	0.00166	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000304	0.00166	CcSEcCtD
Dextropropoxyphene—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000304	0.0148	CbGpPWpGaD
Dextropropoxyphene—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.000302	0.00164	CcSEcCtD
Dextropropoxyphene—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000302	0.00164	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.0003	0.00163	CcSEcCtD
Dextropropoxyphene—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000299	0.00163	CcSEcCtD
Dextropropoxyphene—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.000299	0.00163	CcSEcCtD
Dextropropoxyphene—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.000296	0.00161	CcSEcCtD
Dextropropoxyphene—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000296	0.00161	CcSEcCtD
Dextropropoxyphene—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000296	0.00161	CcSEcCtD
Dextropropoxyphene—Shock—Indinavir—acquired immunodeficiency syndrome	0.000296	0.00161	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000295	0.00161	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000295	0.00161	CcSEcCtD
Dextropropoxyphene—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000294	0.0016	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000294	0.0016	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000293	0.0016	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000293	0.0016	CcSEcCtD
Dextropropoxyphene—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000293	0.00159	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000293	0.00159	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.000293	0.00159	CcSEcCtD
Dextropropoxyphene—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000292	0.00159	CcSEcCtD
Dextropropoxyphene—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.00029	0.00158	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.00029	0.00158	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000288	0.00157	CcSEcCtD
Dextropropoxyphene—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000287	0.00156	CcSEcCtD
Dextropropoxyphene—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000286	0.00156	CcSEcCtD
Dextropropoxyphene—OPRK1—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.000286	0.0139	CbGpPWpGaD
Dextropropoxyphene—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000285	0.00155	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000284	0.00155	CcSEcCtD
Dextropropoxyphene—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000283	0.00154	CcSEcCtD
Dextropropoxyphene—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.000283	0.00154	CcSEcCtD
Dextropropoxyphene—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00028	0.00153	CcSEcCtD
Dextropropoxyphene—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000279	0.00152	CcSEcCtD
Dextropropoxyphene—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000279	0.00152	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000279	0.00152	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000279	0.00152	CcSEcCtD
Dextropropoxyphene—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000277	0.00151	CcSEcCtD
Dextropropoxyphene—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000276	0.00151	CcSEcCtD
Dextropropoxyphene—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000276	0.0015	CcSEcCtD
Dextropropoxyphene—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000276	0.0015	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000275	0.0015	CcSEcCtD
Dextropropoxyphene—OPRD1—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.000275	0.0134	CbGpPWpGaD
Dextropropoxyphene—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000274	0.00149	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000274	0.00149	CcSEcCtD
Dextropropoxyphene—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000272	0.00148	CcSEcCtD
Dextropropoxyphene—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000272	0.00148	CcSEcCtD
Dextropropoxyphene—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000272	0.00148	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000271	0.00147	CcSEcCtD
Dextropropoxyphene—Rash—Didanosine—acquired immunodeficiency syndrome	0.00027	0.00147	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00027	0.00147	CcSEcCtD
Dextropropoxyphene—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00027	0.00147	CcSEcCtD
Dextropropoxyphene—OPRK1—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.000269	0.0131	CbGpPWpGaD
Dextropropoxyphene—Headache—Didanosine—acquired immunodeficiency syndrome	0.000268	0.00146	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000268	0.00146	CcSEcCtD
Dextropropoxyphene—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000268	0.00146	CcSEcCtD
Dextropropoxyphene—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000267	0.00146	CcSEcCtD
Dextropropoxyphene—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000267	0.00146	CcSEcCtD
Dextropropoxyphene—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000267	0.00145	CcSEcCtD
Dextropropoxyphene—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000267	0.00145	CcSEcCtD
Dextropropoxyphene—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000267	0.013	CbGpPWpGaD
Dextropropoxyphene—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000266	0.00145	CcSEcCtD
Dextropropoxyphene—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000266	0.00145	CcSEcCtD
Dextropropoxyphene—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000265	0.00144	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000265	0.00144	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000264	0.00144	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000264	0.00144	CcSEcCtD
Dextropropoxyphene—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000263	0.00143	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.00026	0.00142	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00026	0.00141	CcSEcCtD
Dextropropoxyphene—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000259	0.00141	CcSEcCtD
Dextropropoxyphene—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000257	0.0014	CcSEcCtD
Dextropropoxyphene—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000257	0.0014	CcSEcCtD
Dextropropoxyphene—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000257	0.0014	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000256	0.00139	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000255	0.00139	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000254	0.00139	CcSEcCtD
Dextropropoxyphene—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000254	0.00139	CcSEcCtD
Dextropropoxyphene—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000254	0.00138	CcSEcCtD
Dextropropoxyphene—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000254	0.00138	CcSEcCtD
Dextropropoxyphene—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000253	0.00138	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000253	0.00138	CcSEcCtD
Dextropropoxyphene—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000253	0.00137	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000251	0.00136	CcSEcCtD
Dextropropoxyphene—OPRM1—brain—acquired immunodeficiency syndrome	0.00025	0.0246	CbGeAlD
Dextropropoxyphene—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.00025	0.00136	CcSEcCtD
Dextropropoxyphene—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000249	0.00136	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000249	0.00135	CcSEcCtD
Dextropropoxyphene—OPRD1—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.000248	0.0121	CbGpPWpGaD
Dextropropoxyphene—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000248	0.00135	CcSEcCtD
Dextropropoxyphene—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000247	0.00135	CcSEcCtD
Dextropropoxyphene—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000247	0.00134	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000246	0.00134	CcSEcCtD
Dextropropoxyphene—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000246	0.00134	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000246	0.00134	CcSEcCtD
Dextropropoxyphene—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000246	0.00134	CcSEcCtD
Dextropropoxyphene—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000245	0.00134	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000245	0.00134	CcSEcCtD
Dextropropoxyphene—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000245	0.00133	CcSEcCtD
Dextropropoxyphene—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000245	0.00133	CcSEcCtD
Dextropropoxyphene—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000244	0.00133	CcSEcCtD
Dextropropoxyphene—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000243	0.00132	CcSEcCtD
Dextropropoxyphene—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000243	0.00132	CcSEcCtD
Dextropropoxyphene—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000243	0.00132	CcSEcCtD
Dextropropoxyphene—CYP2C8—blood—acquired immunodeficiency syndrome	0.000243	0.0238	CbGeAlD
Dextropropoxyphene—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000242	0.00132	CcSEcCtD
Dextropropoxyphene—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000242	0.00132	CcSEcCtD
Dextropropoxyphene—OPRM1—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.000242	0.0118	CbGpPWpGaD
Dextropropoxyphene—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000242	0.00132	CcSEcCtD
Dextropropoxyphene—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000241	0.00131	CcSEcCtD
Dextropropoxyphene—OPRK1—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.000241	0.0117	CbGpPWpGaD
Dextropropoxyphene—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000239	0.0013	CcSEcCtD
Dextropropoxyphene—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000238	0.0013	CcSEcCtD
Dextropropoxyphene—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000238	0.00129	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000238	0.00129	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000237	0.00129	CcSEcCtD
Dextropropoxyphene—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000237	0.00129	CcSEcCtD
Dextropropoxyphene—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000236	0.00129	CcSEcCtD
Dextropropoxyphene—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000235	0.00128	CcSEcCtD
Dextropropoxyphene—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000235	0.00128	CcSEcCtD
Dextropropoxyphene—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000235	0.00128	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000235	0.00128	CcSEcCtD
Dextropropoxyphene—Rash—Stavudine—acquired immunodeficiency syndrome	0.000234	0.00128	CcSEcCtD
Dextropropoxyphene—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000234	0.00128	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000234	0.00127	CcSEcCtD
Dextropropoxyphene—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000234	0.00127	CcSEcCtD
Dextropropoxyphene—Headache—Stavudine—acquired immunodeficiency syndrome	0.000233	0.00127	CcSEcCtD
Dextropropoxyphene—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000233	0.00127	CcSEcCtD
Dextropropoxyphene—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000233	0.00127	CcSEcCtD
Dextropropoxyphene—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000232	0.00127	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000232	0.00126	CcSEcCtD
Dextropropoxyphene—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000232	0.00126	CcSEcCtD
Dextropropoxyphene—OPRD1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000231	0.0113	CbGpPWpGaD
Dextropropoxyphene—Rash—Abacavir—acquired immunodeficiency syndrome	0.000231	0.00126	CcSEcCtD
Dextropropoxyphene—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000231	0.00126	CcSEcCtD
Dextropropoxyphene—Headache—Abacavir—acquired immunodeficiency syndrome	0.00023	0.00125	CcSEcCtD
Dextropropoxyphene—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000229	0.00125	CcSEcCtD
Dextropropoxyphene—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000227	0.00124	CcSEcCtD
Dextropropoxyphene—OPRM1—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.000227	0.0111	CbGpPWpGaD
Dextropropoxyphene—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000227	0.00124	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000226	0.00123	CcSEcCtD
Dextropropoxyphene—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000226	0.0222	CbGeAlD
Dextropropoxyphene—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000226	0.00123	CcSEcCtD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000225	0.011	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000225	0.0221	CbGeAlD
Dextropropoxyphene—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000225	0.00122	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000224	0.00122	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000224	0.00122	CcSEcCtD
Dextropropoxyphene—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000223	0.00122	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000222	0.00121	CcSEcCtD
Dextropropoxyphene—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000222	0.00121	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000221	0.00121	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000221	0.0012	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000221	0.0012	CcSEcCtD
Dextropropoxyphene—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000221	0.0012	CcSEcCtD
Dextropropoxyphene—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000219	0.00119	CcSEcCtD
Dextropropoxyphene—OPRK1—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.000218	0.0106	CbGpPWpGaD
Dextropropoxyphene—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000218	0.00118	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000217	0.00118	CcSEcCtD
Dextropropoxyphene—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000216	0.00117	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000216	0.00117	CcSEcCtD
Dextropropoxyphene—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000216	0.00117	CcSEcCtD
Dextropropoxyphene—CYP2C9—blood—acquired immunodeficiency syndrome	0.000215	0.0211	CbGeAlD
Dextropropoxyphene—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000215	0.00117	CcSEcCtD
Dextropropoxyphene—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000215	0.00117	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000215	0.00117	CcSEcCtD
Dextropropoxyphene—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000214	0.00116	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000213	0.00116	CcSEcCtD
Dextropropoxyphene—OPRD1—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.00021	0.0102	CbGpPWpGaD
Dextropropoxyphene—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000209	0.00114	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000209	0.00114	CcSEcCtD
Dextropropoxyphene—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000209	0.00114	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000207	0.00113	CcSEcCtD
Dextropropoxyphene—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000207	0.00113	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000206	0.00112	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000206	0.00112	CcSEcCtD
Dextropropoxyphene—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000206	0.00112	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000206	0.00112	CcSEcCtD
Dextropropoxyphene—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000205	0.00112	CcSEcCtD
Dextropropoxyphene—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000204	0.00111	CcSEcCtD
Dextropropoxyphene—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000204	0.00111	CcSEcCtD
Dextropropoxyphene—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000204	0.00111	CcSEcCtD
Dextropropoxyphene—OPRM1—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.000203	0.0099	CbGpPWpGaD
Dextropropoxyphene—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000203	0.00111	CcSEcCtD
Dextropropoxyphene—OPRK1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000203	0.00987	CbGpPWpGaD
Dextropropoxyphene—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000203	0.0011	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.0002	0.00109	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000199	0.00109	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000199	0.00108	CcSEcCtD
Dextropropoxyphene—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000199	0.00108	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000199	0.00108	CcSEcCtD
Dextropropoxyphene—OPRM1—IL4-mediated signaling events—IL10—acquired immunodeficiency syndrome	0.000198	0.00965	CbGpPWpGaD
Dextropropoxyphene—OPRM1—IL4-mediated signaling events—CD40LG—acquired immunodeficiency syndrome	0.000198	0.00965	CbGpPWpGaD
Dextropropoxyphene—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000198	0.00108	CcSEcCtD
Dextropropoxyphene—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000197	0.00107	CcSEcCtD
Dextropropoxyphene—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000195	0.00106	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000194	0.00106	CcSEcCtD
Dextropropoxyphene—OPRM1—IL4-mediated signaling events—IL4—acquired immunodeficiency syndrome	0.000193	0.00939	CbGpPWpGaD
Dextropropoxyphene—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000192	0.00105	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000191	0.00104	CcSEcCtD
Dextropropoxyphene—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000191	0.00104	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.00019	0.00104	CcSEcCtD
Dextropropoxyphene—Rash—Indinavir—acquired immunodeficiency syndrome	0.00019	0.00103	CcSEcCtD
Dextropropoxyphene—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000189	0.00103	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.00103	CcSEcCtD
Dextropropoxyphene—Headache—Indinavir—acquired immunodeficiency syndrome	0.000188	0.00103	CcSEcCtD
Dextropropoxyphene—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000188	0.00102	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000186	0.00101	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000185	0.00101	CcSEcCtD
Dextropropoxyphene—OPRK1—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.000184	0.00897	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000184	0.00896	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.000184	0.00895	CbGpPWpGaD
Dextropropoxyphene—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.000993	CcSEcCtD
Dextropropoxyphene—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000181	0.000983	CcSEcCtD
Dextropropoxyphene—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.00018	0.000982	CcSEcCtD
Dextropropoxyphene—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00018	0.000979	CcSEcCtD
Dextropropoxyphene—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000179	0.000975	CcSEcCtD
Dextropropoxyphene—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000179	0.000974	CcSEcCtD
Dextropropoxyphene—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000179	0.000972	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.00097	CcSEcCtD
Dextropropoxyphene—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000178	0.000969	CcSEcCtD
Dextropropoxyphene—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000174	0.000945	CcSEcCtD
Dextropropoxyphene—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000173	0.000941	CcSEcCtD
Dextropropoxyphene—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000172	0.0169	CbGeAlD
Dextropropoxyphene—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000172	0.000936	CcSEcCtD
Dextropropoxyphene—OPRM1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000172	0.00835	CbGpPWpGaD
Dextropropoxyphene—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000171	0.000933	CcSEcCtD
Dextropropoxyphene—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000171	0.000932	CcSEcCtD
Dextropropoxyphene—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00017	0.000927	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.000926	CcSEcCtD
Dextropropoxyphene—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.00017	0.0167	CbGeAlD
Dextropropoxyphene—OPRD1—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.00017	0.00825	CbGpPWpGaD
Dextropropoxyphene—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000169	0.000919	CcSEcCtD
Dextropropoxyphene—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000167	0.0081	CbGpPWpGaD
Dextropropoxyphene—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000166	0.000905	CcSEcCtD
Dextropropoxyphene—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.000901	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000166	0.000901	CcSEcCtD
Dextropropoxyphene—CYP3A4—blood—acquired immunodeficiency syndrome	0.000164	0.0161	CbGeAlD
Dextropropoxyphene—CYP2D6—blood—acquired immunodeficiency syndrome	0.000162	0.0159	CbGeAlD
Dextropropoxyphene—OPRK1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000161	0.00786	CbGpPWpGaD
Dextropropoxyphene—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000161	0.000879	CcSEcCtD
Dextropropoxyphene—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00016	0.000871	CcSEcCtD
Dextropropoxyphene—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00016	0.00087	CcSEcCtD
Dextropropoxyphene—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000158	0.000863	CcSEcCtD
Dextropropoxyphene—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000158	0.000862	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000158	0.00086	CcSEcCtD
Dextropropoxyphene—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000157	0.000857	CcSEcCtD
Dextropropoxyphene—OPRM1—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.000156	0.00758	CbGpPWpGaD
Dextropropoxyphene—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000154	0.000837	CcSEcCtD
Dextropropoxyphene—OPRD1—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.000153	0.00746	CbGpPWpGaD
Dextropropoxyphene—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000153	0.000831	CcSEcCtD
Dextropropoxyphene—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.00083	CcSEcCtD
Dextropropoxyphene—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.00083	CcSEcCtD
Dextropropoxyphene—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.000825	CcSEcCtD
Dextropropoxyphene—CYP2C8—brain—acquired immunodeficiency syndrome	0.000151	0.0148	CbGeAlD
Dextropropoxyphene—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000149	0.000813	CcSEcCtD
Dextropropoxyphene—OPRK1—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.000149	0.00724	CbGpPWpGaD
Dextropropoxyphene—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000147	0.000799	CcSEcCtD
Dextropropoxyphene—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000146	0.0071	CbGpPWpGaD
Dextropropoxyphene—OPRM1—TCR Signaling Pathway—CD8A—acquired immunodeficiency syndrome	0.000146	0.00708	CbGpPWpGaD
Dextropropoxyphene—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000792	CcSEcCtD
Dextropropoxyphene—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000791	CcSEcCtD
Dextropropoxyphene—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000787	CcSEcCtD
Dextropropoxyphene—OPRD1—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.000144	0.00702	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.000144	0.00702	CbGpPWpGaD
Dextropropoxyphene—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.000782	CcSEcCtD
Dextropropoxyphene—OPRD1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00014	0.00682	CbGpPWpGaD
Dextropropoxyphene—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000137	0.000746	CcSEcCtD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000136	0.00664	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.000135	0.00654	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000133	0.0131	CbGeAlD
Dextropropoxyphene—OPRM1—TCR Signaling Pathway—CCR5—acquired immunodeficiency syndrome	0.000133	0.00648	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000131	0.0129	CbGeAlD
Dextropropoxyphene—OPRD1—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000129	0.0063	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000128	0.0126	CbGeAlD
Dextropropoxyphene—OPRD1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000127	0.00617	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.000126	0.00615	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.000126	0.00615	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000126	0.0124	CbGeAlD
Dextropropoxyphene—OPRM1—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.000126	0.00612	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000123	0.006	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000123	0.00598	CbGpPWpGaD
Dextropropoxyphene—OPRD1—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000122	0.00592	CbGpPWpGaD
Dextropropoxyphene—OPRD1—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000122	0.00592	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00012	0.00584	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000119	0.00578	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000114	0.00553	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.000114	0.00553	CbGpPWpGaD
Dextropropoxyphene—OPRK1—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000113	0.00552	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000113	0.00549	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000111	0.00541	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.00011	0.00534	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.000107	0.0052	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.000107	0.0052	CbGpPWpGaD
Dextropropoxyphene—OPRK1—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000107	0.00519	CbGpPWpGaD
Dextropropoxyphene—OPRK1—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000107	0.00519	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000105	0.00512	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000104	0.00507	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000104	0.00506	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000103	0.00501	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—brain—acquired immunodeficiency syndrome	0.0001	0.00984	CbGeAlD
Dextropropoxyphene—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	9.98e-05	0.00485	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	9.9e-05	0.00482	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	9.88e-05	0.00481	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	9.67e-05	0.00471	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	9.67e-05	0.00471	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	9.62e-05	0.00468	CbGpPWpGaD
Dextropropoxyphene—OPRM1—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	9.59e-05	0.00467	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	9.4e-05	0.00457	CbGpPWpGaD
Dextropropoxyphene—OPRD1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	9.26e-05	0.0045	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	9.02e-05	0.00439	CbGpPWpGaD
Dextropropoxyphene—OPRM1—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	9.02e-05	0.00439	CbGpPWpGaD
Dextropropoxyphene—OPRM1—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	9.02e-05	0.00439	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	8.9e-05	0.00433	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	8.8e-05	0.00428	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	8.67e-05	0.00422	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	8.66e-05	0.00421	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	8.48e-05	0.00413	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	8.48e-05	0.00413	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	8.43e-05	0.0041	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	8.37e-05	0.00407	CbGpPWpGaD
Dextropropoxyphene—OPRM1—TCR Signaling Pathway—CD4—acquired immunodeficiency syndrome	8.36e-05	0.00407	CbGpPWpGaD
Dextropropoxyphene—OPRD1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	8.34e-05	0.00406	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	8.13e-05	0.00396	CbGpPWpGaD
Dextropropoxyphene—OPRK1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	8.12e-05	0.00395	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	7.83e-05	0.00381	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	7.74e-05	0.00376	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	7.62e-05	0.00371	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	7.6e-05	0.0037	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	7.37e-05	0.00358	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	7.37e-05	0.00358	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	7.36e-05	0.00358	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	7.33e-05	0.00356	CbGpPWpGaD
Dextropropoxyphene—OPRK1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	7.31e-05	0.00356	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	7.2e-05	0.0035	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	7.17e-05	0.00349	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	7.17e-05	0.00349	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	7.02e-05	0.00341	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	6.87e-05	0.00334	CbGpPWpGaD
Dextropropoxyphene—OPRM1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	6.86e-05	0.00334	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	6.79e-05	0.0033	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	6.63e-05	0.00323	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	6.51e-05	0.00317	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	6.46e-05	0.00314	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	6.46e-05	0.00314	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	6.45e-05	0.00314	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	6.42e-05	0.00312	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	6.31e-05	0.00307	CbGpPWpGaD
Dextropropoxyphene—OPRM1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	6.18e-05	0.00301	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	6.15e-05	0.00299	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	5.81e-05	0.00283	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	5.81e-05	0.00282	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	5.73e-05	0.00279	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	5.71e-05	0.00278	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	5.7e-05	0.00277	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	5.6e-05	0.00273	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	5.46e-05	0.00266	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	5.46e-05	0.00266	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	5.45e-05	0.00265	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	5.33e-05	0.00259	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	5.2e-05	0.00253	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	5.05e-05	0.00246	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	4.91e-05	0.00239	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	4.91e-05	0.00239	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	4.82e-05	0.00235	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—TAT—acquired immunodeficiency syndrome	4.77e-05	0.00232	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	4.64e-05	0.00226	CbGpPWpGaD
Dextropropoxyphene—OPRM1—TCR Signaling Pathway—IL6—acquired immunodeficiency syndrome	4.52e-05	0.0022	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	4.45e-05	0.00216	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	4.43e-05	0.00215	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	4.43e-05	0.00215	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	4.25e-05	0.00207	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	4.25e-05	0.00207	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	4.16e-05	0.00203	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	4.16e-05	0.00203	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	4.15e-05	0.00202	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—AGPS—acquired immunodeficiency syndrome	4.05e-05	0.00197	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	4.02e-05	0.00196	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	3.9e-05	0.0019	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	3.88e-05	0.00189	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.84e-05	0.00187	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	3.78e-05	0.00184	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	3.78e-05	0.00184	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	3.74e-05	0.00182	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	3.73e-05	0.00181	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	3.73e-05	0.00181	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	3.65e-05	0.00178	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	3.65e-05	0.00178	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	3.53e-05	0.00172	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.37e-05	0.00164	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	3.31e-05	0.00161	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	3.31e-05	0.00161	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	3.29e-05	0.0016	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	3.28e-05	0.0016	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.17e-05	0.00154	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	3.15e-05	0.00153	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	3.15e-05	0.00153	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.12e-05	0.00152	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	3.09e-05	0.0015	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	3.09e-05	0.0015	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—TAT—acquired immunodeficiency syndrome	2.98e-05	0.00145	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.98e-05	0.00145	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.88e-05	0.0014	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.85e-05	0.00139	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.85e-05	0.00139	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.83e-05	0.00138	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.8e-05	0.00136	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.8e-05	0.00136	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.78e-05	0.00135	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.74e-05	0.00133	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.63e-05	0.00128	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.59e-05	0.00126	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—AGPS—acquired immunodeficiency syndrome	2.54e-05	0.00123	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.52e-05	0.00123	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.5e-05	0.00122	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.48e-05	0.00121	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	2.45e-05	0.00119	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	2.43e-05	0.00118	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.38e-05	0.00116	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.35e-05	0.00114	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.31e-05	0.00112	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.3e-05	0.00112	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.27e-05	0.00111	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.23e-05	0.00109	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.23e-05	0.00109	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.13e-05	0.00104	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.11e-05	0.00103	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.1e-05	0.00102	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	2.08e-05	0.00101	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.08e-05	0.00101	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	2.07e-05	0.001	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.96e-05	0.000953	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.96e-05	0.000953	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.95e-05	0.000947	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.92e-05	0.000934	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.76e-05	0.000856	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.7e-05	0.000827	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.67e-05	0.000814	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.65e-05	0.000805	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.65e-05	0.000805	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.65e-05	0.000802	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	1.6e-05	0.000779	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.53e-05	0.000745	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.5e-05	0.000728	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.49e-05	0.000725	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.47e-05	0.000714	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.45e-05	0.000703	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	1.36e-05	0.000663	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.34e-05	0.000653	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.31e-05	0.000639	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.26e-05	0.000613	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.24e-05	0.000603	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.22e-05	0.000594	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.17e-05	0.000569	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.13e-05	0.000552	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.11e-05	0.00054	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	9.51e-06	0.000463	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.84e-06	0.00043	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.8e-06	0.000428	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—ALB—acquired immunodeficiency syndrome	8.31e-06	0.000404	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.75e-06	0.000377	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.72e-06	0.000375	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.55e-06	0.000319	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.52e-06	0.000317	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—ALB—acquired immunodeficiency syndrome	5.2e-06	0.000253	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.2e-06	0.000253	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.56e-06	0.000222	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	4.27e-06	0.000208	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	4.24e-06	0.000206	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.85e-06	0.000187	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	2.79e-06	0.000136	CbGpPWpGaD
